Literature DB >> 2393554

Contribution of gluconeogenesis to overall glucose output in diabetic and nondiabetic men.

A Consoli1, N Nurjhan.   

Abstract

Increased hepatic glucose output is the main cause of fasting hyperglycemia in non-insulin dependent diabetes mellitus. Due to difficulties in obtaining a quantitative estimate of gluconeogenesis in vivo, the relative contribution of gluconeogenesis and glycogenolysis to this increased hepatic glucose output was unknown. The application in vivo of a new isotopic approach based on a mathematical model of the Krebs cycle enabled us to obtain a quantitative estimate of gluconeogenesis in vivo. Using this approach, gluconeogenesis was found to account for approximately 28% and approximately 97% of overall hepatic glucose output in healthy volunteers in the postabsorptive and in the fasted state respectively. When this technique was used to compare gluconeogenesis rates in non-insulin dependent diabetes mellitus and nondiabetic patients, gluconeogenesis was found to be increased threefold in the patients with non-insulin dependent diabetes mellitus (12.7 +/- 1.6 mu vs 3.6 +/- 0.6 mumol/Kg/min) and to be significantly correlated with fasting plasma glucose. Furthermore, the increase in gluconeogenesis could explain more than 80% of the increase in overall hepatic glucose output in patients with non-insulin dependent diabetes mellitus. In conclusion, in non-insulin dependent diabetes mellitus, gluconeogenesis, as measured by a new isotopic technique, is increased and this increase represents the main cause for increased overall hepatic glucose output and fasting hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393554     DOI: 10.3109/07853899009147268

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  6 in total

1.  Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice.

Authors:  R H J Bandsma; A Grefhorst; T H van Dijk; F H van der Sluijs; A Hammer; D-J Reijngoud; F Kuipers
Journal:  Diabetologia       Date:  2004-12-01       Impact factor: 10.122

2.  Characterization of the allosteric binding pocket of human liver fructose-1,6-bisphosphatase by protein crystallography and inhibitor activity studies.

Authors:  L F Iversen; M Brzozowski; S Hastrup; R Hubbard; J S Kastrup; I K Larsen; L Naerum; L Nørskov-Lauridsen; P B Rasmussen; L Thim; F C Wiberg; K Lundgren
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

Review 3.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

4.  Developmental and tissue-specific regulation of hepatocyte nuclear factor 4-alpha (HNF4-alpha) isoforms in rodents.

Authors:  Samena Dean; Justin I Tang; Jonathan R Seckl; Moffat J Nyirenda
Journal:  Gene Expr       Date:  2010

5.  Prenatal programming of hepatocyte nuclear factor 4alpha in the rat: A key mechanism in the 'foetal origins of hyperglycaemia'?

Authors:  M J Nyirenda; S Dean; V Lyons; K E Chapman; J R Seckl
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

6.  Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis.

Authors:  Adrian Soto-Mota; Nicholas G Norwitz; Rhys D Evans; Kieran Clarke
Journal:  Endocrinol Diabetes Metab       Date:  2021-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.